Tuberculosis Trial, Recruiting (NCT06565845)

Tuberculosis Trial, Recruiting NCT06565845 Sponsor: First Affiliated Hospital of Harbin Medical University Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT06565845 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 15 and 65 years old and are not currently breastfeeding
Your condition has been confirmed by a tissue sample (biopsy) test showing a specific type of breast inflammation called GLM
Your liver and kidneys are working normally, based on recent test results

Who may not be able to join:

You are currently breastfeeding or pregnant
You have a known allergy to any of the following medications: rifampin, isoniazid, or ethambutol
You have been diagnosed with a cancerous (malignant) breast tumour at the same time
You have serious underlying health conditions
The trial doctors have determined for other reasons that the trial may not be appropriate for you (confirm with trial site)
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jing Feng, First Affiliated Hospital of Harbin Medical University

Phone: +86-0451-85552102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06565845

Sponsor: First Affiliated Hospital of Harbin Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Tuberculosis

Trial contact: +86-0451-85552102

More information: https://clinicaltrials.gov/study/NCT06565845

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 15 and 65 years old and are not currently breastfeeding
Your condition has been confirmed by a tissue sample (biopsy) test showing a specific type of breast inflammation called GLM
Your liver and kidneys are working normally, based on recent test results

Who may not be able to join:

You are currently breastfeeding or pregnant
You have a known allergy to any of the following medications: rifampin, isoniazid, or ethambutol
You have been diagnosed with a cancerous (malignant) breast tumour at the same time
You have serious underlying health conditions
The trial doctors have determined for other reasons that the trial may not be appropriate for you (confirm with trial site)
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

First Affiliated Hospital of Harbin Medical University

Registry

ClinicalTrials.gov

Start date

19 August 2024

Est. completion

19 September 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Differences in the cure rate of the three treatment modalities; Differences in the recurrence rate of the three treatment modalities; Differences in the incidence of adverse reactions of the three treatment modalities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov